Metraipolis › archive › dc_ec75497d85d7
Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers — Europe PMC PMID:41301714
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41301714
- DOI
- 10.3390/biomedicines13112619
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T01:27:24.958Z
- SHA-256 of the archived text
c5ba4eda37ce0765ab77fa99f812cdcd6862f1a240e4d86765c6a29068cec3d5- Stable URL of this page
https://metraipolis.com/documento/dc_ec75497d85d7
How to cite
Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers — Europe PMC PMID:41301714 — Europe PMC (en), https://europepmc.org/article/MED/41301714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec75497d85d7 (Metraipolis archive dc_ec75497d85d7, sha256 c5ba4eda37ce0765ab77fa99f812cdcd6862f1a240e4d86765c6a29068cec3d5)
BibTeX
@misc{dcec75497d85d7,
title = {Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers — Europe PMC PMID:41301714},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41301714},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec75497d85d7; sha256 c5ba4eda37ce0765ab77fa99f812cdcd6862f1a240e4d86765c6a29068cec3d5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41301714. Agents can read the archived copy with the MCP tool read_document.